news aktuell GmbH

JP Hospitality acquires tradition-rich vintage hotel in heart of Madonna di Campiglio’s town centre

29.6.2022 10:00:14 CEST | news aktuell GmbH | Pressemelding

Del
Fourth acquisition by Viennese investor group in 2022

Vienna, 28th of June 2022

The JP Hospitality Investors Club has acquired Hotel Milano in Madonna di Campiglio (altitude: 1,600 metres), a property surrounded by the breathtaking mountain scenery of the Brenta Dolomites.

Daniel Jelitzka, founder of JP Immobilien Group and chairman of the Advisory Board at JP Hospitality, explained that the acquisition of Hotel Milano fits into the Investors Club’s strategy very well: “Madonna di Campiglio is a one-of-a-kind ski town in the northern Italian Alps with its own unique charm, and it offers the ideal conditions for a wide range of winter and summer tourist activities. With a refurbished, hip hotel and an attractive range of culinary offerings, we will cover the resilient and very much in demand lifestyle segment here.”

The hotel offers around 50 rooms and is located in the middle of the pedestrian zone in the Alpine village of Madonna di Campiglio, roughly a one-minute walk from the valley chairlift station for the famous World Cup race course. In collaboration with an international operator, the hotel will be renovated and repositioned as a mid to upscale Alpine lifestyle hotel.

“We will give an existing property a modern update with a clear design and develop it into an Alpine lifestyle hotel located in one of Europe’s most attractive Alpine winter and summer tourist destinations,” commented Lukas Euler-Rolle, CEO of JP Hospitality, enthusiastically.

Gebhard Schachermayer, CAM of JP Hospitality, pointed out that “the vintage hotel features an ideal location in the heart of the town centre and has tremendous catch-up potential with modern F&B and wellness offerings.”

Download

www.jpi.at

For enquiries, please contact:

Petra Menasse-Eibensteiner / JP Immobilien

+43 699 126 39 220

petra@menassemenasse.at 

Om news aktuell GmbH

news aktuell GmbH
news aktuell GmbH
Mittelweg 144
20148 Hamburg

+49 (0)40 4113-32589http://www.newsaktuell.de

news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.

Følg pressemeldinger fra news aktuell GmbH

Registrer deg med din e-postadresse under for å få de nyeste sakene fra news aktuell GmbH på e-post fortløpende. Du kan melde deg av når som helst.

Siste pressemeldinger fra news aktuell GmbH

Democracy News Alliance: Fiscal strength doesn't guarantee public goods delivery, US study finds21.10.2026 09:55:20 CEST | Press release

New York/DNA - A newly released study of US state government performance found strong partisan and regional patterns within three pillars of governance: democratic accountability, state capacity and public goods provision. Yet, the US states’ outcomes differ in important ways from international comparisons, as the three governance dimensions show limited correlation, the researchers found.

Grünenthal advances proprietary Nociceptin Receptor (NOP) Agonist into Phase II trial in acute pain20.10.2026 10:17:49 CEST | Press release

Potential first-in-class, selective nociceptin receptor (NOP) agonist that aims to provide safe, effective treatment for moderate to severe acute pain. Following successful Phase I results earlier this year demonstrating an excellent safety profile, the program has now progressed to Phase II. The randomized, double-blind, double-dummy, placebo- and active controlled, 2-part Phase II trial will evaluate the safety, tolerability and efficacy of this novel NOP agonist in patients post bunionectomy surgery. Grünenthal anticipates reporting results in early 2028.

I vårt presserom finner du alle våre siste pressemeldinger, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye